Search results
Results From The WOW.Com Content Network
The Monthly Index of Medical Specialities or MIMS is a pharmaceutical prescribing reference guide published in the United Kingdom since 1959 by Haymarket Media Group.MIMS is also published internationally by various organisations, including in Australia, New Zealand, China, Hong Kong, India, Indonesia, Japan, Korea, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam.
MIMS Ireland is used by the Irish Medicines Board to convey information on drug safety, [2] [3] and is a "recommended text" in the premises requirements for pharmacies issued by the Pharmaceutical Society of Ireland (PSI). [4] It is also listed as a reference for the use of drugs in sports by the Irish Sports Council. [5] [6]
Martindale: The Complete Drug Reference is a reference book published by Pharmaceutical Press listing some 6,000 drugs and medicines used throughout the world, including details of over 125,000 proprietary preparations. It also includes almost 700 disease treatment reviews.
Irish Medicines Formulary (IMF) [1] [2] is a medicines reference for doctors, nurses, pharmacists and dentists, [3] providing medicines information which is medico-legally relevant in Ireland. As of March 2025, the publication will only be published in digital format (IMF Edition 36 due for publication during March 2025).
The Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals, more commonly known by its abbreviation CPS, [1] is a reference book that contains drug monographs and numerous features which help healthcare professionals prescribe and use drugs safely and appropriately.
The British National Formulary (BNF) is a United Kingdom (UK) pharmaceutical reference book that contains a wide spectrum of information and advice on prescribing and pharmacology, along with specific facts and details about many medicines available on the UK National Health Service (NHS).
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Lixisenatide is a member of the class of glucagon-like peptide-1 receptor agonist drugs, each of which activates the GLP-1 receptor. GLP-1 is a hormone that helps pancreatic beta cells to secrete insulin in response to high blood sugar.